NOVEL Trademark

Trademark Overview

On Monday, June 2, 2008, a trademark application was filed for NOVEL with the United States Patent and Trademark Office. The USPTO has given the NOVEL trademark a serial number of 77488701. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, April 8, 2011. This trademark is owned by Novel Laboratories, Inc.. The NOVEL trademark is filed in the Pharmaceutical Products category with the following description:

Full line of pharmaceutical products for use in connection with humans
novel

General Information

Serial Number77488701
Word MarkNOVEL
Filing DateMonday, June 2, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, April 8, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "novel" where the letter "o" consists of a tear drop enclosing a flask in front of a circle.
Goods and ServicesFull line of pharmaceutical products for use in connection with humans
Pseudo MarkNOVEL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 5, 2008
Primary Code005
First Use Anywhere DateTuesday, July 13, 2010
First Use In Commerce DateTuesday, July 13, 2010

Trademark Owner History

Party NameNovel Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameNovel Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events

Event DateEvent Description
Friday, April 8, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, April 8, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, September 10, 2010NON-FINAL ACTION MAILED
Friday, September 10, 2010SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, August 24, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 29, 2010USE AMENDMENT FILED
Tuesday, August 24, 2010EXTENSION 1 GRANTED
Thursday, July 29, 2010EXTENSION 1 FILED
Tuesday, August 24, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 29, 2010TEAS EXTENSION RECEIVED
Thursday, July 29, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, February 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2009NOTICE OF PUBLICATION
Tuesday, October 6, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 2, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, September 27, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 27, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 25, 2009ASSIGNED TO LIE
Tuesday, September 22, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 23, 2009LETTER OF SUSPENSION MAILED
Monday, March 23, 2009SUSPENSION LETTER WRITTEN
Thursday, March 5, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 5, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 22, 2008DATA MODIFICATION COMPLETED
Monday, September 22, 2008ASSIGNED TO LIE
Monday, September 22, 2008NON-FINAL ACTION MAILED
Friday, September 19, 2008NON-FINAL ACTION WRITTEN
Friday, September 12, 2008ASSIGNED TO EXAMINER
Friday, June 6, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, June 5, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

novel connection humans products pharmaceutical line full